Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H21NO2 |
Molecular Weight | 235.322 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)(CN(C)C)OC(=O)C1=CC=CC=C1
InChI
InChIKey=FDMBBCOBEAVDAO-UHFFFAOYSA-N
InChI=1S/C14H21NO2/c1-5-14(2,11-15(3)4)17-13(16)12-9-7-6-8-10-12/h6-10H,5,11H2,1-4H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15957711Curator's Comment: The description was created based on several sources, including
https://www.drugs.com/international/amylocaine.html | https://www.ncbi.nlm.nih.gov/pubmed/15957711 | https://www.ncbi.nlm.nih.gov/pubmed/9068339 | https://www.ncbi.nlm.nih.gov/pubmed/8881614
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15957711
Curator's Comment: The description was created based on several sources, including
https://www.drugs.com/international/amylocaine.html | https://www.ncbi.nlm.nih.gov/pubmed/15957711 | https://www.ncbi.nlm.nih.gov/pubmed/9068339 | https://www.ncbi.nlm.nih.gov/pubmed/8881614
Amylocaine (trade name Stovaine) is a local anesthetic, that was widely used for spinal anesthesia in Caesarean section. The dose used would produce anesthesia for up to 1 h. Reports of the use of spinal analgesia for abdominal and perineal surgery in infants are found from several centers during the first half of the twentieth century. However, this agent often fails to provide good maternal sensory block and currently, Amylocaine has been replaced with new anesthetics.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2363032 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9068339 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8881614 |
Primary | Stovaine Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://jpet.aspetjournals.org/content/9/4/231.short
5, 10, or 20 mg/kg
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9068339
Female Wistar rats Cerebral cortex homogenate were used for activity evaluation. Binding assays were performed in 1-ml volumes of Tris HC1 buffer for 90 min at 20°C using cere- brocortical membranes containing approximately 200 mkg of protein. After incubation, each sample was filtered under vacuum through Whatman GF/B filters using a Brandel cell harvester to separate bound and free radioactivity. Filter retained (bound) radioactivity was extracted for at least 8 h in 4 ml of scintillation fluid before estimation using a beta-scintillation counter. Estimated radioactivity was quench cor¬rected with an average [3H] counting efficiency of 60.4%. In order to determine if local anaesthetics interacted with DHP binding sites on L-type Ca2+ channels, the DHP binding site was labelled with [3H]PN200-110. Increasing concentrations of unlabelled displacer (local anaesthetics) were then added. Displacement of [3H]PN200-110 binding by local anaesthetics indicates that they are interact-ing at the same site as the radiolabel. A fixed concentration of [3H]PN200-110 (approximately 0.2 nmol litre-1) was displaced by the following unlabelled agents Amylocaine (30-10000mkM)
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m1877
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000077416
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
AMYLOCAINE
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
DB09088
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
644-26-8
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
206
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
QRW683O56T
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
C015677
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
211-411-1
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
SUB12893MIG
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
40660
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | RxNorm | ||
|
10767
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
DTXSID6047862
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL1740065
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY | |||
|
C72170
Created by
admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)